BREAKING NEWS: Pinnacle Medicines raises $89M for oral peptide development - Meet Peptide Pioneers in April

BREAKING NEWS: FDA Approves Johnson & Johnson's IL-23' ICOTYDE™ receptor - Meet J&J and More in April

BREAKING NEWS: Endevica Announces Spinout of Kalohexis to Advance First- and Best-in-Class Therapeutics Harnessing the Melanocortin System to Treat Obesity and Metabolic Diseases - Meet Them in April

BREAKING NEWS: Daiichi Sankyo to collaborate with Meddenovo's AI-powered Mexa technology to advance the de novo design of cyclic peptides - Learn More in April

BREAKING NEWS: Unnatural Products raise a further $45M in Series B financing for a new class of medicines built on synthetic macrocyclic peptides - meet them in April

Industry News: Novo Nordisk teams with Langer-founded biotech Vivtex for oral obesity drugs - meet them in April

Industry News: Novartis signs macrocyclic deal with Unnatural Products - meet them in April

Industry News: Zonsen PepLib Biotech Enters Global R&D Collaboration and License Agreement with Lilly - meet them in April

Industry News: PeptiDream Announces Achievement Milestone with Johnson & Johnson - meet them in April

Maryna Gorelik

Principal Scientist ProteinQure

Seminars

Tuesday 28th April 2026

Spotlight Case Study 1: Development of Peptide-Drug Conjugates for Targeted Tissue & Cell Type Delivery

View all Speakers

View Event Brochure

Maryna Gorelik

Maryna Gorelik

Seminars

Venue

Map

Contact

Join Our Team

About Us

Explore Our Products

Stay Connected

Search

Organized By